26-Dec-2025
No headlines found.
LeMaitre to Participate in Upcoming Investor Conferences
Globe Newswire (Wed, 12-Nov 4:13 PM ET)
LeMaitre Q3 2025 Financial Results
Globe Newswire (Thu, 6-Nov 4:05 PM ET)
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
Globe Newswire (Thu, 9-Oct 5:53 PM ET)
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
Lemaitre Vascular trades on the NASDAQ stock market under the symbol LMAT.
As of December 26, 2025, LMAT stock price declined to $83.78 with 89,243 million shares trading.
LMAT has a beta of 0.62, meaning it tends to be less sensitive to market movements. LMAT has a correlation of 0.10 to the broad based SPY ETF.
LMAT has a market cap of $1.90 billion. This is considered a Small Cap stock.
Last quarter Lemaitre Vascular reported $61 million in Revenue and $.75 earnings per share. This fell short of revenue expectation by $-1 million and exceeded earnings estimates by $.18.
In the last 3 years, LMAT traded as high as $109.58 and as low as $43.69.
The top ETF exchange traded funds that LMAT belongs to (by Net Assets): IJR, SDVY, VTI, IWM, VXF.
LMAT has underperformed the market in the last year with a price return of -9.8% while the SPY ETF gained +16.0%. LMAT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -0.2% and -0.3%, respectively, while the SPY returned +4.6% and +1.5%, respectively.
LMAT support price is $82.82 and resistance is $85.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LMAT shares will trade within this expected range on the day.